---
document_datetime: 2023-09-21 18:44:34
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/iclusig-epar-all-authorised-presentations_en.pdf
document_name: iclusig-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.990697
conversion_datetime: 2025-12-15 20:15:33.284725
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA EU Number    | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging   | Pack size   |
|-----------------|-------------------|------------|-----------------------|---------------------------|-----------------------|-------------|
| EU/1/13/839/001 | Iclusig           | 15 mg      | Film coated tablet    | Oral use                  | Bottle                | 60 tablets  |
| EU/1/13/839/002 | Iclusig           | 15 mg      | Film coated tablet    | Oral use                  | Bottle                | 180 tablets |
| EU/1/13/839/003 | Iclusig           | 45 mg      | Film coated tablet    | Oral use                  | Bottle                | 30 tablets  |
| EU/1/13/839/004 | Iclusig           | 45 mg      | Film coated tablet    | Oral use                  | Bottle                | 90 tablets  |
| EU/1/13/839/005 | Iclusig           | 15 mg      | Film coated tablet    | Oral use                  | Bottle                | 30 tablets  |
| EU/1/13/839/006 | Iclusig           | 30 mg      | Film coated tablet    | Oral use                  | Bottle                | 30 tablets  |